Onchocerciasis

Onchocerciasis, also known as river blindness, is a disease caused by infection with the parasitic worm Onchocerca volvulus. Symptoms include severe itching, bumps under the skin, and blindness. It is the second-most common cause of blindness due to infection, after trachoma.The parasite worm is spread by the bites of a black fly of the Simulium type. Usually, many bites are required before infection occurs. These flies live near rivers, hence the common name of the disease. Once inside a person, the worms create larvae that make their way out to the skin, where they can infect the next black fly …

Wikipedia

Publications

WHO: World Health Organization · 13 November 2024 English

[‎iv]‎, 18 p.

trypanosomiasis Acoziborole 320 mg ODF Scabies and onchocerciasis L-praziquantel 150 mg ODT Emodepside L-praziquantel


WHO: World Health Organization · 6 November 2024 English

12 p.

schistosomiasis, lymphatic filariasis and onchocerciasis carry a larger disease burden than other NTDs human African trypanosomiasis (HAT), scabies, onchocerciasis and visceral leishmaniasis (VL). KEY MESSAGES schistosomiasis, lymphatic filariasis and onchocerciasis have, in comparison, a larger disease burden human African trypanosomiasis, scabies and onchocerciasis, and visceral leishmaniasis (9). Table 1 below Scabies and onchocerciasis Ivermectin 1 mg or 1.5 mg ODT (to be confirmed) Emodepside (onchocerciasis) Moxidectin


WHO: World Health Organization · 6 October 2024 English

xvi, 174 p.

for other diseases such as malaria, HIV/AIDS, onchocerciasis • Inadequacy of the national technical platform


WHO: World Health Organization · 4 October 2024 French

14

opportunity for synergy. Not only STH but also onchocerciasis serology can be added to the TAS platform surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria


WHO: World Health Organization · 4 October 2024 French

14 p

opportunity for synergy. Not only STH but also onchocerciasis serology can be added to the TAS platform surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria


WHO: World Health Organization · 27 September 2024 French

6 p

545 Progress in eliminating onchocerciasis in the WHO Region of the Americas: Report from the Inter- Inter- American Conference on Onchocerciasis (IACO) 2023 Human onchocerciasis (river blindness) is caused Dohme1 since 1987 to control or eliminate onchocerciasis through repeated community-wide mass drug EPIDEMIOLOGICAL RECORD, NO 39, 27 SEPTEMBER 2024 The Onchocerciasis Elimination Program for the Amer- icas (OEPA)2 WHO has since verified the elim- ination of onchocerciasis transmission in 4 countries: Colombia (2013)


Amref: Amref Health Africa · 23 March 2024 English

months after the last treatment round in 2019 and 2021, respectively, the high endemicity of onchocerciasis in Mvolo, the community’s awareness of the condition, which was targeted by an awareness campaign

epidemiology in Mvolo County, South Sudan, an onchocerciasis-endemic area pntd.0012059 with high epilepsy all of the content of peer review and author onchocerciasis-associated manifestations (itching and blindness) NEGLECTED TROPICAL DISEASES Epilepsy in an onchocerciasis-endemic county under ivermectin current study number 1296723N). The the potential impact of onchocerciasis control efforts and underscores the need to Author summary In areas where many people have onchocerciasis, a parasitic infection spread by female blackflies


Arrow Lakes Hospital · 2024 English

Mansonella perstans Elephantiasis Loiasis Onchocerciasis Wucheriasis FILARS Clotted blood (7mL) or 2mL


GSK: GlaxoSmithKline (India) · 2024 English

to any of the excipients • in patients with onchocerciasis due to the occurrence of cutaneous and/or systemic


GBMC: Greater Baltimore Medical Center · 2024 English

DR, Gilles HM, Aziz MA. The chemotherapy of onchocerciasis X. An assess- ment of four-single dose treatment treatment regimes of MK-933 (Iver- mectin) in human onchocerciasis. Ann Trop Med Parasitol. 1985; 79(1):63e78 Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight


View more